MORGAN STANLEY - GLYCOMIMETICS INC ownership

GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 36 filers reported holding GLYCOMIMETICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of GLYCOMIMETICS INC
ValueSharesWeighting
Q3 2023$60,578
-64.4%
40,385
-58.8%
0.00%
Q2 2023$170,400
-18.9%
97,931
-41.3%
0.00%
Q1 2023$210,143
+324.4%
166,780
+920.6%
0.00%
Q4 2022$49,516
+106.3%
16,342
-62.5%
0.00%
Q3 2022$24,000
-7.7%
43,630
+0.0%
0.00%
Q2 2022$26,000
-48.0%
43,620
-0.1%
0.00%
Q1 2022$50,000
-34.2%
43,652
-17.9%
0.00%
Q4 2021$76,000
-48.6%
53,155
-21.7%
0.00%
Q3 2021$148,000
+43.7%
67,924
+52.9%
0.00%
Q2 2021$103,000
-82.9%
44,414
-77.8%
0.00%
Q1 2021$603,000
-70.7%
200,273
-63.4%
0.00%
Q4 2020$2,056,000
+119.4%
546,756
+79.1%
0.00%
Q3 2020$937,000
-62.4%
305,288
-53.9%
0.00%
-100.0%
Q2 2020$2,493,000
+127.9%
662,937
+38.1%
0.00%
Q1 2020$1,094,000
-24.3%
479,992
+75.6%
0.00%
Q4 2019$1,446,000
+3515.0%
273,318
+2772.2%
0.00%
Q3 2019$40,000
+150.0%
9,516
+589.6%
0.00%
Q2 2019$16,000
-80.7%
1,380
-79.2%
0.00%
Q1 2019$83,000
-83.6%
6,625
-87.6%
0.00%
Q4 2018$507,000
-38.3%
53,563
-6.3%
0.00%
Q3 2018$822,000
-30.1%
57,134
-21.6%
0.00%
Q2 2018$1,176,000
+557.0%
72,915
+558.4%
0.00%
Q1 2018$179,000
+214.0%
11,074
+229.2%
0.00%
Q4 2017$57,000
+5600.0%
3,364
+3441.1%
0.00%
Q3 2017$1,000
-98.8%
95
-98.8%
0.00%
Q2 2017$85,000
-50.0%
7,614
-75.8%
0.00%
Q1 2017$170,000
-60.3%
31,446
-55.2%
0.00%
Q4 2016$428,000
+2575.0%
70,152
+3110.6%
0.00%
Q3 2016$16,000
+433.3%
2,185
+378.1%
0.00%
Q2 2016$3,000
-78.6%
457
-80.3%
0.00%
Q1 2016$14,000
-56.2%
2,324
-58.0%
0.00%
Q4 2015$32,000
-45.8%
5,529
-47.2%
0.00%
Q3 2015$59,000
-38.5%
10,462
-13.1%
0.00%
Q2 2015$96,000
-4.0%
12,033
+0.0%
0.00%
Q1 2015$100,000
+78.6%
12,032
+81.8%
0.00%
Q2 2014$56,000
-88.7%
6,620
-78.2%
0.00%
Q1 2014$495,00030,3490.00%
Other shareholders
GLYCOMIMETICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,000,000$5,220,0000.73%
NEA Management Company, LLC 4,764,440$8,290,1260.63%
Artal Group S.A. 8,589,064$14,9450.46%
BVF INC/IL 9,544,262$16,607,0160.46%
Sargent Investment Group, LLC 108,000$187,9200.05%
Intellectus Partners, LLC 73,475$127,8470.04%
XTX Topco Ltd 29,998$52,1970.01%
AXA S.A. 1,631,509$2,838,8260.01%
ACADIAN ASSET MANAGEMENT LLC 1,149,656$1,9990.01%
TOBIAS FINANCIAL ADVISORS, INC. 15,000$26,1000.01%
View complete list of GLYCOMIMETICS INC shareholders